Danish healthcare company Novo Nordisk has dropped prices for its weight-loss and diabetes drug Wegoy, the injectable ...
The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Novo Nordisk A/S (NYSE:NVO) on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy ...
The company announced that the starting dose of Wegovy (0.25 mg) will now cost Rs 2,712 per week, down from Rs.4,336 ...
Novo Nordisk India reduces the price of its obesity medication Wegovy by 37%. Starting dose now available at Rs 2,712 per week.
Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second ...
With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...
Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide ...
Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback